Dilazep Decreases Lipopolysaccharide-Induced Nitric Oxide and TNF-α Synthesis in RAW 264 Cells
Dilazep dihydrochloride (dilazep) is used to treat ischemic dysfunction, although the mechanisms underlying the anti-inflammatory effects of the drug have not yet been elucidated. The present study evaluated the anti-inflammatory effect of dilazep. Dilazep suppressed the production of nitric oxide (...
Saved in:
Main Authors: | Ryusuke Nakatsuka (Author), Tadashige Nozaki (Author), Mitsuko Shinohara (Author), Kiyoshi Ohura (Author) |
---|---|
Format: | Book |
Published: |
Elsevier,
2010-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Upregulating Nonneuronal Cholinergic Activity Decreases TNF Release from Lipopolysaccharide-Stimulated RAW264.7 Cells
by: Yi Lv, et al.
Published: (2014) -
Utility of salivary biomarker for stress induced by dental treatment
by: Kiyoshi Ohura, et al.
Published: (2012) -
Gene Expression Profile of Dental Pulp Cells During Differentiation Into an Adipocyte Lineage
by: Tadashige Nozaki, et al.
Published: (2011) -
Inhibitory Effect of Trimidox on Lipopolysaccharide-Induced Nitric Oxide Production in RAW 264.7 Macrophages
by: Syu-ichi Kanno, et al.
Published: (2007) -
Liquid Perfluorochemical Inhibits Inducible Nitric Oxide Synthase Expression and Nitric Oxide Formation in Lipopolysaccharide-Treated RAW 264.7 Macrophages
by: Li-Ping Chang, et al.
Published: (2009)